Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
PubMed: 17332148 AOD 9604 Versus Placebo in Obese Adults: A 52-Week Randomized, Double-Blind Extension Study human rct Hefti FF, Hefti F, Lichtensteiger W, et al
Some people feel improvement in fatigue sooner, but blood markers and neurologic symptoms may take longer to assess
Food and Drug Administration
For severe cases, a bigger dose might be given first, followed by smaller doses later
AOD-9604 has no approved therapeutic use anywhere in the world
Most patients describe the injection as a "quick pinch" with minimal pain during insertion
US$ 21.92
US$ 29.96
US$ 29.73
US$ 23.96
US$ 28.08
US$ 23.80
US$ 29.95
US$ 28.81
